EDBI announces changes to management that will take effect from 1 February 2023.
Investing in a resilient and sustainable future EDBI Sustainability Report 2021/2022 Recognising the importance of how investors play an influential role in encouraging sustainability, EDBI is doing our part to contribute to Singapore’s commitments towards a more sustainable world. Our inaugural sustainability report charts our role as a strategic investor and outlines our ESG practices …
DataStax, the real-time data company, announced that it has secured $115 million in funding led by the Growth Equity business within Goldman Sachs, with participation from Rokos Capital and Singapore-based global investor EDBI.
Tessa Therapeutics, a clinical-stage cell therapy company developing next-generation cancer treatments for hematological malignancies and solid tumors, today announced the close of a US$126 million Series A financing round.
Aspen Neuroscience, Inc., a private biotechnology company developing autologous cell therapies, including the first iPSC-derived autologous neuron replacement treatment for Parkinson’s disease, announced the close of its Series B funding round of $147.5 million.
Neuron Mobility, Canada’s fastest-growing shared e-scooter and e-bike operator, announces it has successfully raised US$43.5 million in Series B funding. This follows 19 months of significant growth and brings the company’s total funding to US$77.7 million.
Ambiq®, a leading developer of ultra-low-power semiconductor solutions that deliver a multifold increase in energy efficiency, announces the grand opening of its new Technology Design Center in Singapore.
RVAC Medicines, an emerging messenger RNA (mRNA) platform company incubated in Singapore by CBC Group, announced the completion of its series B financing, bringing the company’s total funds raised since its inception in June 2021 to US$140 million.